There are many different ways that investors can participate in the cannabis industry’s tremendous growth, but True Leaf Medicine Inc. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) represents one of the most interesting. In addition to its diverse exposure, both in terms of geography and end markets, the company’s Regulation A+ crowdfunding campaign, which launches today, November 30, enables investors to purchase equity in a unique way that provides benefits that aren’t typical for stocks purchased through a brokerage.
Why Invest in True Leaf?
True Leaf Medicine Inc. is one of the only cannabis companies with federally legal products in both the United States and Canada. For investors, this translates to diversified exposure to the cannabis industry both in terms of geography and target markets. The company’s management team is confident in its future prospects with a nearly 40% stake in the company, which differs from many investment opportunities where management teams own a very little – or no – stake in the company. True Leaf’s Chairman of the Board, Michael Harcourt, is the former Premier of British Columbia and the former Mayor of Vancouver, lending a level of experience and gravitas unusual in the cannabis industry.
True Leaf Medicine
True Leaf Medicine was one of the earliest applicants to become a licensed producer of medical cannabis under the ACMPR program. The company is currently in the final stages of the application and approval process. According to Deloitte, the country’s legal cannabis industry could be worth upwards of $22.6 billion following the legalization of both medical and recreational marijuana. Some companies and analysts believe that there could be a significant shortfall in production given the strong demand and bottleneck of suppliers.
Last month, the company acquired an option to purchase a 40-acre site in Lumby, British Columbia where it plans to retrofit an existing 16,000 square foot building to produce an initial 2,500 kilograms per year of dried cannabis. Management believes that this capacity could be expanded to a million square feet facility capable of producing 125,000 kilograms of dried cannabis per year, making it among the largest licensed producers. British Columbia is also becoming established as the “Napa Valley” of cannabis.
True Leaf Pet
True Leaf Pet was established in 2015 to pioneer and market hemp-focused products for the pet industry. After launching the True Hemp™ product line in Canada, the U.S., and Europe, the company become one of the first hemp-based pet product lines marketed worldwide. The APPA projects that pet spending in the U.S. alone will reach nearly $70 billion this year, including nearly $15 billion spent on pet supplies and over-the-counter supplements. Notably, the company’s products contain no CBD or THC, which makes them legal everywhere.
Last month, the company announced that it significantly expanded distribution of its True Hemp™ supplements both online and through brick-and-mortar stores. The supplements are now available for sale on Amazon.com, WholesalePet.com, and through more than 400 specialty Pet Supplies Plus stores. This extensive distribution across more than 1,600 stores in the United States sets it apart from many competitors that have only a small online presence in the market and limited sales over a short lifespan
Benefits of Crowdfunding
True Leaf Medicine Inc. already trades on the Canadian Stock Exchange under the ticker symbol “MJ”, but in the United States, it’s looking to raise $10 million in a Regulation A+ crowdfunding campaign. Under the offering, investors would be able to purchase a stake in the company for as little as C$350 and become one of the first investors in a crowdfunding campaign focused on the cannabis industry, with free trading shares not subject to escrow.
The company benefits from a longer-term shareholder base that is less likely to sell equity in the short-term, as well as the lighter regulatory requirements associated with Regulation A+ versus listing on a U.S. stock exchange. Investors benefit from unique rewards that aren’t possible using traditional stock brokerages, including free trading shares, special shout outs, discounts, products, and much more, according to the company.
True Leaf Medicine Inc. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) represents a compelling investment opportunity in the cannabis industry given its diverse exposure in terms of geography and end markets. Investors interested in the company may want to consider its Regulation A+ offering as a compelling way to invest given the ancillary benefits and advantages to the company.
If you are interested in this investing opportunity, please visit invest.trueleaf.com